In Treatment of Bacterial infections Moxiall C Dry Syrup contains two different medicines, Amoxycillin and Clavulanic Acid, that work together to kill the bacteria that cause infections. Amoxycillin works by stopping the growth of bacteria. Clavulanic Acid reduces resistance and enhances the activity of Amoxycillin against bacteria. This combination medicine can be used to treat many different bacterial infections such as ear, sinus, throat, lung, urinary tract, skin, teeth, joints, and bones. It usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
Consuming alcohol with Moxiall C Dry Syrup does not cause any harmful side effects.
Moxiall C Dry Syrup is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Moxiall C Dry Syrup is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Moxiall C Dry Syrup may cause side effects which could affect your ability to drive. Moxiall C Dry Syrup may cause side effects such as allergic reactions, dizziness or fits that may make you unfit to drive.
Moxiall C Dry Syrup should be used with caution in patients with kidney disease. Dose adjustment of Moxiall C Dry Syrup may be needed. Please consult your doctor. Use of this medicine is not recommended in patients with severe kidney disease.
Moxiall C Dry Syrup should be used with caution in patients with liver disease. Dose adjustment of Moxiall C Dry Syrup may be needed. Please consult your doctor. Regular monitoring of liver function tests is recommended while you are taking this medicine
If you miss a dose of Moxiall C Dry Syrup, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Impact Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Inga Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)